Contribute Try STAT+ Today

Every Tuesday, Moderna’s top doctor gets about $1 million richer.

As the world awaits results from Moderna’s pivotal Covid-19 vaccine study, Chief Medical Officer Tal Zaks has been selling his existing stock like clockwork every week through pre-scheduled trades — earning him more than $50 million since the dawn of the pandemic, according to disclosures made to the Securities and Exchange Commission.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Pretty lazy reporting here. Why not talk to a Securities lawyer for clarity? Once COVID hit and Moderna was pursuing a vaccine there is no way he would have been able to amend his 10b5 plan because he had material inside info. The question you should be asking was when he put his plan in place. Assuming it was done pre COVID then the plan is doing exactly what the securities laws require and allow to prevent insider trading. You can do better reporting than this!

  • “his trades were done through a plan established by the SEC that allows insiders to sell stock legally” – So?

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy